Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association.
Sebastiani M, Luppi F, Sambataro G, Castillo Villegas D, Cerri S, Tomietto P, Cassone G, Bocchino M, Atienza-Mateo B, Cameli P, Moya Alvarado P, Faverio P, Bargagli E, Vancheri C, Gonzalez-Gay MA, Clini E, Salvarani C, Manfredi A. Sebastiani M, et al. Among authors: castillo villegas d. J Clin Med. 2021 Jun 9;10(12):2548. doi: 10.3390/jcm10122548. J Clin Med. 2021. PMID: 34207641 Free PMC article.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: results of a Delphi survey.
Funke-Chambour M, Albera C, Bendstrup E, Costabel U, Grutters JC, Harari S, Johannson KA, Kreuter M, Strambu I, Vancheri C, Varone F, Vitulo P, Wuyts WA, Martinez F, Raghu G; Erice participants; Erice participants:. Funke-Chambour M, et al. Eur Respir J. 2021 Apr 29;57(4):2004219. doi: 10.1183/13993003.04219-2020. Print 2021 Apr. Eur Respir J. 2021. PMID: 33419886 Free article. No abstract available.
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.
Cano-Jiménez E, Vázquez Rodríguez T, Martín-Robles I, Castillo Villegas D, Juan García J, Bollo de Miguel E, Robles-Pérez A, Ferrer Galván M, Mouronte Roibas C, Herrera Lara S, Bermudo G, García Moyano M, Rodríguez Portal JA, Sellarés Torres J, Narváez J, Molina-Molina M. Cano-Jiménez E, et al. Among authors: castillo villegas d. Sci Rep. 2021 Apr 28;11(1):9184. doi: 10.1038/s41598-021-88734-2. Sci Rep. 2021. PMID: 33911185 Free PMC article.
Predictors and changes of physical activity in idiopathic pulmonary fibrosis.
Badenes-Bonet D, Rodó-Pin A, Castillo-Villegas D, Vicens-Zygmunt V, Bermudo G, Hernández-González F, Portillo K, Martínez-Llorens J, Chalela R, Caguana O, Sellarés J, Molina-Molina M, Duran X, Gea J, Rodríguez-Chiaradia DA, Balcells E. Badenes-Bonet D, et al. Among authors: castillo villegas d. BMC Pulm Med. 2022 Sep 9;22(1):340. doi: 10.1186/s12890-022-02134-4. BMC Pulm Med. 2022. PMID: 36085057 Free PMC article.
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.
Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG; INMARK trial investigators. Maher TM, et al. Lancet Respir Med. 2019 Sep;7(9):771-779. doi: 10.1016/S2213-2600(19)30255-3. Epub 2019 Jul 17. Lancet Respir Med. 2019. PMID: 31326319 Free article. Clinical Trial.
Respiratory diseases registries in the national registry of rare diseases.
Lara Gallego B, Abaitua Borda I, Galán Gil G, Castillo Villegas D, Casanova Espinosa Á, Cano Jiménez E, Ojanguren Arranz I, Posada de la Paz M. Lara Gallego B, et al. Among authors: castillo villegas d. Arch Bronconeumol. 2014 Sep;50(9):397-403. doi: 10.1016/j.arbres.2014.02.007. Epub 2014 Apr 1. Arch Bronconeumol. 2014. PMID: 24703816 English, Spanish.
[No title available]
[No authors listed] [No authors listed] PMID: 35312523
Biological Biomarkers in Respiratory Diseases.
García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García-Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, Sánchez-de-la-Torre M, Sibila O, Martínez-García MA. García-Río F, et al. Among authors: castillo villegas d. Arch Bronconeumol. 2022 Apr;58(4):323-333. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17. Arch Bronconeumol. 2022. PMID: 35312522 Free article. Review. English, Spanish.
[The clinical view through the Archives: the clinical notes of 2009].
Samolski D, Martín Robles I, Castillo Villegas D. Samolski D, et al. Among authors: castillo villegas d. Arch Bronconeumol. 2010 Dec;46(12):652-7. doi: 10.1016/j.arbres.2010.10.001. Epub 2010 Nov 10. Arch Bronconeumol. 2010. PMID: 21071130 Review. Spanish.
22 results